APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Panic Attack Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Panic Attack Treatment Market Outlook and Growth Opportunities 2026

Report ID 174022120431 December 2025193 pages

Choose your research edition.

Industry ResearchPanic Attack Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Panic Attack Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Panic Attack Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Panic Attack Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Panic Attack Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Panic Attack Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Panic Attack Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Panic Attack Treatment market include Noven Pharmaceuticals, Inc., Recordati Rare Diseases(Recordati), Actavis Generics, Bristol Myers Squibb(BMS), Baxter International Inc., Sumitomo Dainippon Pharma, GlaxoSmithKline plc., Pfizer,Inc. and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Panic Attack Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Panic Attack Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Panic Attack Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Panic Attack Treatment market.

Panic Attack Treatment Segment by Company

Noven Pharmaceuticals, Inc.

Recordati Rare Diseases(Recordati)

Actavis Generics

Bristol Myers Squibb(BMS)

Baxter International Inc.

Sumitomo Dainippon Pharma

GlaxoSmithKline plc.

Pfizer,Inc.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Shionogi & Co., Ltd.

Panic Attack Treatment Segment by Type

Selective Serotonin Reuptake Inhibitor(SSRI)

Benzodiazepines(BZD)

Serotonin Norepinephrine Reuptake Inhibitor(SNRI)

Panic Attack Treatment Segment by Application

Hospitals

Mental Healthcare Centers

Others

Panic Attack Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Panic Attack Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Panic Attack Treatment key companies, revenue, market share, and recent developments.

3. To split the Panic Attack Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Panic Attack Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Panic Attack Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Panic Attack Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Panic Attack Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Panic Attack Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Panic Attack Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Panic Attack Treatment industry.

Chapter 3: Detailed analysis of Panic Attack Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Panic Attack Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Panic Attack Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Panic Attack Treatment Industry Trends Table 2. Panic Attack Treatment Industry Drivers Table 3. Panic Attack Treatment Industry Opportunities and Challenges Table 4. Panic Attack Treatment Industry Restraints Table 5. Global Panic Attack Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Panic Attack Treatment Revenue Share by Company (2021-2026) Table 7. Global Panic Attack Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Panic Attack Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Panic Attack Treatment Company, Product Type & Application Table 10. Global Panic Attack Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Panic Attack Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Selective Serotonin Reuptake Inhibitor(SSRI) Table 15. Significant Companies of Benzodiazepines(BZD) Table 16. Significant Companies of Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Table 17. Global Panic Attack Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Panic Attack Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Panic Attack Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Panic Attack Treatment Sales Value Share by Type (2021-2026) Table 21. Global Panic Attack Treatment Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Mental Healthcare Centers Table 24. Significant Companies of Others Table 25. Global Panic Attack Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Panic Attack Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Panic Attack Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Panic Attack Treatment Sales Value Share by Application (2021-2026) Table 29. Global Panic Attack Treatment Sales Value Share by Application (2027-2032) Table 30. Global Panic Attack Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Panic Attack Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Panic Attack Treatment Sales Value Share by Region (2021-2026) Table 33. Global Panic Attack Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Panic Attack Treatment Sales Value Share by Region (2027-2032) Table 35. Global Panic Attack Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Panic Attack Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Panic Attack Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Panic Attack Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Panic Attack Treatment Sales Value Market Share by Country (2027-2032) Table 40. Noven Pharmaceuticals, Inc. Company Information Table 41. Noven Pharmaceuticals, Inc. Business Overview Table 42. Noven Pharmaceuticals, Inc. Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio Table 44. Noven Pharmaceuticals, Inc. Recent Development Table 45. Recordati Rare Diseases(Recordati) Company Information Table 46. Recordati Rare Diseases(Recordati) Business Overview Table 47. Recordati Rare Diseases(Recordati) Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio Table 49. Recordati Rare Diseases(Recordati) Recent Development Table 50. Actavis Generics Company Information Table 51. Actavis Generics Business Overview Table 52. Actavis Generics Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Actavis Generics Panic Attack Treatment Product Portfolio Table 54. Actavis Generics Recent Development Table 55. Bristol Myers Squibb(BMS) Company Information Table 56. Bristol Myers Squibb(BMS) Business Overview Table 57. Bristol Myers Squibb(BMS) Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio Table 59. Bristol Myers Squibb(BMS) Recent Development Table 60. Baxter International Inc. Company Information Table 61. Baxter International Inc. Business Overview Table 62. Baxter International Inc. Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Baxter International Inc. Panic Attack Treatment Product Portfolio Table 64. Baxter International Inc. Recent Development Table 65. Sumitomo Dainippon Pharma Company Information Table 66. Sumitomo Dainippon Pharma Business Overview Table 67. Sumitomo Dainippon Pharma Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio Table 69. Sumitomo Dainippon Pharma Recent Development Table 70. GlaxoSmithKline plc. Company Information Table 71. GlaxoSmithKline plc. Business Overview Table 72. GlaxoSmithKline plc. Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio Table 74. GlaxoSmithKline plc. Recent Development Table 75. Pfizer,Inc. Company Information Table 76. Pfizer,Inc. Business Overview Table 77. Pfizer,Inc. Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer,Inc. Panic Attack Treatment Product Portfolio Table 79. Pfizer,Inc. Recent Development Table 80. Eli Lilly and Company Company Information Table 81. Eli Lilly and Company Business Overview Table 82. Eli Lilly and Company Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lilly and Company Panic Attack Treatment Product Portfolio Table 84. Eli Lilly and Company Recent Development Table 85. F. Hoffmann-La Roche Ltd Company Information Table 86. F. Hoffmann-La Roche Ltd Business Overview Table 87. F. Hoffmann-La Roche Ltd Panic Attack Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio Table 89. F. Hoffmann-La Roche Ltd Recent Development Table 90. Abbott Laboratories Company Information Table 91. Abbott Laboratories Business Overview Table 92. Abbott Laboratories Panic Attack Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Abbott Laboratories Panic Attack Treatment Product Portfolio Table 94. Abbott Laboratories Recent Development Table 95. Shionogi & Co., Ltd. Company Information Table 96. Shionogi & Co., Ltd. Business Overview Table 97. Shionogi & Co., Ltd. Panic Attack Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio Table 99. Shionogi & Co., Ltd. Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Panic Attack Treatment Product Image Figure 2. Global Panic Attack Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Panic Attack Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Selective Serotonin Reuptake Inhibitor(SSRI) Image Figure 8. Benzodiazepines(BZD) Image Figure 9. Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Image Figure 10. Global Panic Attack Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Panic Attack Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Panic Attack Treatment Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Mental Healthcare Centers Image Figure 15. Others Image Figure 16. Global Panic Attack Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Panic Attack Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Panic Attack Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Panic Attack Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Panic Attack Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Panic Attack Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Panic Attack Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Panic Attack Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Panic Attack Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Panic Attack Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Panic Attack Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Panic Attack Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Panic Attack Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Panic Attack Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Panic Attack Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Panic Attack Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Selective Serotonin Reuptake Inhibitor(SSRI)
  • Benzodiazepines(BZD)
  • Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Applications
  • Hospitals
  • Mental Healthcare Centers
  • Others
Companies covered
  • Noven Pharmaceuticals, Inc.
  • Recordati Rare Diseases(Recordati)
  • Actavis Generics
  • Bristol Myers Squibb(BMS)
  • Baxter International Inc.
  • Sumitomo Dainippon Pharma
  • GlaxoSmithKline plc.
  • Pfizer,Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Shionogi & Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Panic Attack Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Panic Attack Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Panic Attack Treatment Market Dynamics
  1. 2.1 Panic Attack Treatment Industry Trends
  2. 2.2 Panic Attack Treatment Industry Drivers
  3. 2.3 Panic Attack Treatment Industry Opportunities and Challenges
  4. 2.4 Panic Attack Treatment Industry Restraints
3 Panic Attack Treatment Market by Company
  1. 3.1 Global Panic Attack Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Panic Attack Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Panic Attack Treatment Company Ranking (2024-2026)
  4. 3.4 Global Panic Attack Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Panic Attack Treatment Company Product Type and Application
  6. 3.6 Global Panic Attack Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Panic Attack Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Panic Attack Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Panic Attack Treatment Market by Type
  1. 4.1 Panic Attack Treatment Type Introduction
  2. 4.1.1 Selective Serotonin Reuptake Inhibitor(SSRI)
  3. 4.1.2 Benzodiazepines(BZD)
  4. 4.1.3 Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
  5. 4.2 Global Panic Attack Treatment Sales Value by Type
  6. 4.2.1 Global Panic Attack Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Panic Attack Treatment Sales Value by Type (2021-2032)
  8. 4.2.3 Global Panic Attack Treatment Sales Value Share by Type (2021-2032)
5 Panic Attack Treatment Market by Application
  1. 5.1 Panic Attack Treatment Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Mental Healthcare Centers
  4. 5.1.3 Others
  5. 5.2 Global Panic Attack Treatment Sales Value by Application
  6. 5.2.1 Global Panic Attack Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Panic Attack Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Panic Attack Treatment Sales Value Share by Application (2021-2032)
6 Panic Attack Treatment Regional Value Analysis
  1. 6.1 Global Panic Attack Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Panic Attack Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Panic Attack Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Panic Attack Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Panic Attack Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Panic Attack Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Panic Attack Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Panic Attack Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Panic Attack Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Panic Attack Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Panic Attack Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Panic Attack Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Panic Attack Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Panic Attack Treatment Sales Value Share by Country, 2025 VS 2032
7 Panic Attack Treatment Country-level Value Analysis
  1. 7.1 Global Panic Attack Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Panic Attack Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Panic Attack Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Panic Attack Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Panic Attack Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Panic Attack Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Panic Attack Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Noven Pharmaceuticals, Inc.
  2. 8.1.1 Noven Pharmaceuticals, Inc. Company Information
  3. 8.1.2 Noven Pharmaceuticals, Inc. Business Overview
  4. 8.1.3 Noven Pharmaceuticals, Inc. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio
  6. 8.1.5 Noven Pharmaceuticals, Inc. Recent Developments
  7. 8.2 Recordati Rare Diseases(Recordati)
  8. 8.2.1 Recordati Rare Diseases(Recordati) Company Information
  9. 8.2.2 Recordati Rare Diseases(Recordati) Business Overview
  10. 8.2.3 Recordati Rare Diseases(Recordati) Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio
  12. 8.2.5 Recordati Rare Diseases(Recordati) Recent Developments
  13. 8.3 Actavis Generics
  14. 8.3.1 Actavis Generics Company Information
  15. 8.3.2 Actavis Generics Business Overview
  16. 8.3.3 Actavis Generics Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Actavis Generics Panic Attack Treatment Product Portfolio
  18. 8.3.5 Actavis Generics Recent Developments
  19. 8.4 Bristol Myers Squibb(BMS)
  20. 8.4.1 Bristol Myers Squibb(BMS) Company Information
  21. 8.4.2 Bristol Myers Squibb(BMS) Business Overview
  22. 8.4.3 Bristol Myers Squibb(BMS) Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio
  24. 8.4.5 Bristol Myers Squibb(BMS) Recent Developments
  25. 8.5 Baxter International Inc.
  26. 8.5.1 Baxter International Inc. Company Information
  27. 8.5.2 Baxter International Inc. Business Overview
  28. 8.5.3 Baxter International Inc. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baxter International Inc. Panic Attack Treatment Product Portfolio
  30. 8.5.5 Baxter International Inc. Recent Developments
  31. 8.6 Sumitomo Dainippon Pharma
  32. 8.6.1 Sumitomo Dainippon Pharma Company Information
  33. 8.6.2 Sumitomo Dainippon Pharma Business Overview
  34. 8.6.3 Sumitomo Dainippon Pharma Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio
  36. 8.6.5 Sumitomo Dainippon Pharma Recent Developments
  37. 8.7 GlaxoSmithKline plc.
  38. 8.7.1 GlaxoSmithKline plc. Company Information
  39. 8.7.2 GlaxoSmithKline plc. Business Overview
  40. 8.7.3 GlaxoSmithKline plc. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio
  42. 8.7.5 GlaxoSmithKline plc. Recent Developments
  43. 8.8 Pfizer,Inc.
  44. 8.8.1 Pfizer,Inc. Company Information
  45. 8.8.2 Pfizer,Inc. Business Overview
  46. 8.8.3 Pfizer,Inc. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer,Inc. Panic Attack Treatment Product Portfolio
  48. 8.8.5 Pfizer,Inc. Recent Developments
  49. 8.9 Eli Lilly and Company
  50. 8.9.1 Eli Lilly and Company Company Information
  51. 8.9.2 Eli Lilly and Company Business Overview
  52. 8.9.3 Eli Lilly and Company Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eli Lilly and Company Panic Attack Treatment Product Portfolio
  54. 8.9.5 Eli Lilly and Company Recent Developments
  55. 8.10 F. Hoffmann-La Roche Ltd
  56. 8.10.1 F. Hoffmann-La Roche Ltd Company Information
  57. 8.10.2 F. Hoffmann-La Roche Ltd Business Overview
  58. 8.10.3 F. Hoffmann-La Roche Ltd Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio
  60. 8.10.5 F. Hoffmann-La Roche Ltd Recent Developments
  61. 8.11 Abbott Laboratories
  62. 8.11.1 Abbott Laboratories Company Information
  63. 8.11.2 Abbott Laboratories Business Overview
  64. 8.11.3 Abbott Laboratories Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Abbott Laboratories Panic Attack Treatment Product Portfolio
  66. 8.11.5 Abbott Laboratories Recent Developments
  67. 8.12 Shionogi & Co., Ltd.
  68. 8.12.1 Shionogi & Co., Ltd. Company Information
  69. 8.12.2 Shionogi & Co., Ltd. Business Overview
  70. 8.12.3 Shionogi & Co., Ltd. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio
  72. 8.12.5 Shionogi & Co., Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst